-
1دورية أكاديمية
المؤلفون: Riemer, Tommes, Berndt, Dominique, Böker, Alexander, Lehmann, Josefine, Schrifl, Ulrike, Rau, Saskia, Rübsam, Anne, Joussen, Antonia M., Zeitz, OliverAff1, IDs00417022059528_cor9
المصدر: Graefe's Archive for Clinical and Experimental Ophthalmology: Incorporating German Journal of Ophthalmology. 261(6):1681-1690
-
2دورية أكاديميةAflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
المؤلفون: Alsaedi NG, Alselaimy RM, Alshamrani AA, AlAjmi M, Khandekar R, Al-Dhibi H, Al-Abdullah AA
المصدر: Clinical Ophthalmology, Vol Volume 15, Pp 2975-2980 (2021)
مصطلحات موضوعية: aflibercept, bevacizumab, persistent dme, ranibizumab, vegf switch, vascular endothelial growth factor, Ophthalmology, RE1-994
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Maria Waizel, Margarita G. Todorova, Michael Masyk, Katharina Wolf, Annekatrin Rickmann, Khaled Helaiwa, Björn R. Blanke, Peter Szurman
المصدر: BMC Ophthalmology, Vol 17, Iss 1, Pp 1-7 (2017)
مصطلحات موضوعية: Vascular endothelial growth factor a, Ranibizumab, Aflibercept, Bevacizumab, VEGF switch, Vascular endothelial growth factor, Ophthalmology, RE1-994
وصف الملف: electronic resource
-
4Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
المؤلفون: Muhammed AlAjmi, Abdulelah A. Al-Abdullah, Abdulaziz A Alshamrani, Hassan Al-Dhibi, Ruba M Alselaimy, Rajiv Khandekar, Nasser G Alsaedi
المصدر: Clinical Ophthalmology (Auckland, N.Z.)
مصطلحات موضوعية: medicine.medical_specialty, genetic structures, Bevacizumab, education, Diabetic macular edema, bevacizumab, chemistry.chemical_compound, Refractory, Ophthalmology, Medicine, persistent DME, ranibizumab, Original Research, Aflibercept, Second-line therapy, vascular endothelial growth factor, business.industry, aflibercept, Clinical Ophthalmology, Retrospective cohort study, eye diseases, Vascular endothelial growth factor, chemistry, VEGF switch, sense organs, Ranibizumab, business, medicine.drug
وصف الملف: text/html
-
5
المؤلفون: Annekatrin Rickmann, Margarita G. Todorova, Peter Szurman, Maria della Volpe Waizel, Björn R. Blanke, Katharina Wolf, Michael Masyk, Khaled Helaiwa
المصدر: BMC Ophthalmology
BMC Ophthalmology, Vol 17, Iss 1, Pp 1-7 (2017)مصطلحات موضوعية: 0301 basic medicine, Male, Visual acuity, genetic structures, Visual Acuity, Angiogenesis Inhibitors, chemistry.chemical_compound, 0302 clinical medicine, lcsh:Ophthalmology, Vascular endothelial growth factor a, Macula Lutea, Aflibercept, Aged, 80 and over, Drug Substitution, General Medicine, Middle Aged, Vascular endothelial growth factor, Bevacizumab, Treatment Outcome, Intravitreal Injections, Female, medicine.symptom, Tomography, Optical Coherence, medicine.drug, Research Article, medicine.medical_specialty, Recombinant Fusion Proteins, 03 medical and health sciences, Ophthalmology, Ranibizumab, medicine, Initial treatment, Humans, In patient, Aged, Retrospective Studies, business.industry, Macular degeneration, medicine.disease, eye diseases, Surgery, 030104 developmental biology, Receptors, Vascular Endothelial Growth Factor, chemistry, lcsh:RE1-994, 030221 ophthalmology & optometry, Wet Macular Degeneration, VEGF switch, sense organs, business, Follow-Up Studies
-
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.